Target intelligence / Profile preview

TMEM202 antisense RNA 1 (TMEM202-AS1)

Target
TMEM202-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

TMEM202 antisense RNA 1 (TMEM202-AS1) is a long non-coding RNA (lncRNA) that is transcribed antisense to the TMEM202 gene[1][5]. Antisense lncRNAs often regulate the expression of their sense partner genes or other genes by affecting splicing, recruiting transcription factors, or modulating mRNA stability, but there is currently no published evidence for a direct functional or disease-related role of TMEM202-AS1 specifically[1][5][2]. It is identifiable in public databases (such as NCBI Gene accession 105370888), but is not considered a therapeutic target (its molecular function, disease relevance, and targetability are not established)[1][5]. If you are seeking structured data for TMEM202-AS1, it should be classified as an antisense lncRNA, with currently unknown physiological and disease linkages, not as an established receptor, enzyme, transporter, or similar druggable target.

02

Biological functions

Regulation of gene expression (by mechanisms such as splicing regulation, recruiting transcription factors, controlling mRNA stability; general for this class)
03

Disease associations

Other (No direct association or detailed function for specific diseases reported for TMEM202-AS1. Other antisense lncRNAs are implicated in cancer and related processes, but a direct role for this gene is unreported in the search results)

Beyond the preview

Go deeper on TMEM202 antisense RNA 1 (TMEM202-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM202 antisense RNA 1 (TMEM202-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call